retatrutide developer eli lilly Strengthens Its Weight Loss Pipeline. Why Could Be the Next Growth Driver for LLY Eli Lilly eyes 2027 approval

Furthermore, there is a correlation between improvements in sperm count and concentration and weight loss linked to GLP-1RA usage

In addition, all participants had at least one documented cardiovascular condition at baseline, limiting the generalizability of the findings to patients without pre-existing cardiovascular disease

This is relevant because muscle-related concerns with tirzepatide are common, and understanding how BMI category affects body composition changes helps set appropriate expectations

The proportion of patients with PCOS who were prescribed semaglutide or tirzepatide increased more than 7-fold over the study period

But results are substantially better when paired with intentional nutrition and training